Target intelligence / Profile preview

Human papillomavirus type 18 L1 major capsid protein (HPV18 L1)

Target
HPV18 L1
Molecular classification
Viral structural protein, Capsid protein, Other
01

Overview

The Human papillomavirus type 18 L1 major capsid protein forms the main structural component of the HPV virion. It self assembles into pentamers, which further organize into an icosahedral shell comprising 72 pentamers linked by disulfide bonds, giving rise to a particle about 50 nm in diameter. The L1 protein binds viral DNA within the virion and plays a critical role in stabilizing and protecting it during intracellular trafficking after cell entry. As the principal antigenic determinant on the virus surface, conformational epitopes on assembled L1 induce strong neutralizing antibody responses. Recombinant expression of this single viral gene enables formation of virus-like particles (VLPs), which are non-infectious yet immunologically indistinguishable from native virions—this property underlies its use in current prophylactic vaccines against oncogenic HPVs such as types 16 and 18.

Other names
HPV18 L1Major capsid protein L1 (HPV18)HPV type 18 major capsid protein
02

Mechanism of action

Induces production of neutralizing antibodies that prevent infection by blocking virus entry into host cells

03

Biological functions

Structural assembly of viral capsidDNA binding within the virionInduction of host immune response (as vaccine antigen)
04

Disease associations

Infection (essential for formation and infectivity of human papillomavirus type 18)Cancer (HPV18 infection is associated with cervical cancer development)
05

Safety considerations

Minimal safety concerns related to targeting this molecule via vaccination; rare allergic reactions may occur with vaccine administration
06

Interacting drugs

None in the sense of small-molecule drugs, but it is targeted by prophylactic vaccines such as Gardasil
07

Biomarkers

Presence/antibody titers against HPV18 L1 are used to monitor immune response to vaccination

Beyond the preview

Go deeper on Human papillomavirus type 18 L1 major capsid protein (HPV18 L1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human papillomavirus type 18 L1 major capsid protein (HPV18 L1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call